Skip to content

*Evaluation of biomarkers in VTE study with capillary blood sample; the EVA-II study*

*Evaluation of biomarkers in VTE study with capillary blood sample; the EVA-II study* - EVA-II

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON55145
Enrollment
300
Registered
2020-02-03
Start date
2020-10-26
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pulmonary embolism venous thrombosis

Interventions

There is a minimal burden and risk for patients participating in the study, as the only intervention is to take an additional blood sample of 11 mL from the same venipuncture as a regular D-dimer te

Sponsors

Jeroen Bosch Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: -Patients with suspected Venous ThromboEmbolism, in whom the GP orders a D-dimer test -Life expectancy more than 3 months

Exclusion criteria

Exclusion criteria: Exclusion criteria are age below 18; anticoagulant treatment (vitamin K, NOAC, low molecular-weight heparin) for other causes than VTE; pregnancy or a life expectancy less than three months. Unwilling to participate in this study.

Design outcomes

Primary

MeasureTime frame
D-dimer result

Secondary

MeasureTime frame
Clinical outcom of VTE diagnosis

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)